Volibo R 0.3/0.5MG Tab

Composition

Metformin (500mg) + Voglibose (0.3mg)

Uses of Volibo R 0.3/0.5MG Tab

Type 2 diabetes mellitus: to control post‑meal (postprandial) blood glucose in adults when diet and exercise alone or single therapy is inadequate.

• •Reduces post‑meal blood sugar spikes
• •Improves overall glycaemic control in type 2 diabetes
• •Rapid mealtime glucose lowering
• •Helps when single therapy is insufficient

How it works

Repaglinide stimulates the pancreas to release insulin quickly after meals, lowering blood glucose. Voglibose inhibits intestinal alpha‑glucosidase enzymes, delaying carbohydrate digestion and glucose absorption, thereby reducing post‑meal sugar spikes.

Directions for use

Take by mouth exactly as prescribed. Usually taken shortly (about 15–30 minutes) before meals; if you skip a meal, skip that dose to reduce hypoglycaemia risk. Swallow with water; follow diet/exercise advice and monitor blood glucose as directed.

Side effects

Common side effects of Volibo R 0.3/0.5MG Tab may include:

• •Hypoglycaemia
• •dizziness
• •headache
• •nausea
• •abdominal pain
• •flatulence